LIA
IPXL

LS Investment Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

LS Investment Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,465
Closed -$48K – 1916
2018
Q1 		$48K Hold
2,465
– – ﹤0.01% 1311
2017
Q4 		$41K Sell
2,465
-354
-13% -$6.49K ﹤0.01% 1365
2017
Q3 		$57K Sell
2,819
-450
-14% -$8.6K ﹤0.01% 1310
2017
Q2 		$53K Hold
3,269
– – ﹤0.01% 1328
2017
Q1 		$41K Hold
3,269
– – ﹤0.01% 1387
2016
Q4 		$43K Buy
3,269
+120
+4% +$2.05K ﹤0.01% 1317
2016
Q3 		$75K Buy
3,149
+229
+8% +$6.16K 0.01% 1095
2016
Q2 		$84K Buy
2,920
+248
+9% +$8.08K 0.01% 1046
2016
Q1 		$86K Buy
2,672
+214
+9% +$7.52K 0.01% 939
2015
Q4 		$105K Sell
2,458
-69
-3% -$2.76K 0.01% 840
2015
Q3 		$89K Hold
2,527
– – 0.01% 896
2015
Q2 		$116K Buy
+2,527
New +$120K 0.01% 827

LS Investment Advisors's IPXL Position: Q2 2018 in Review

LS Investment Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 2,465 shares — an estimated $48K sold.

LS Investment Advisors first reported a position in IPXL in Q2 2015 and held it in 12 quarters. The position peaked at $116K in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • LS Investment Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • LS Investment Advisors sold 2,465 Impax Laboratories, Inc. shares in Q2 2018, an estimated $48K.
  • LS Investment Advisors first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 12 quarters.
  • LS Investment Advisors's Impax Laboratories, Inc. position peaked at $116K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on LS Investment Advisors's 13F filing for Q2 2018, filed 20 Jul 2018.